home / stock / nnvc / nnvc news


NNVC News and Press, NanoViricides Inc. From 05/20/24

Stock Information

Company Name: NanoViricides Inc.
Stock Symbol: NNVC
Market: NYSE
Website: nanoviricides.com

Menu

NNVC NNVC Quote NNVC Short NNVC News NNVC Articles NNVC Message Board
Get NNVC Alerts

News, Short Squeeze, Breakout and More Instantly...

NNVC - Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure

NV-387, A Broad-Spectrum Antiviral with Strong Activity Against RSV, Influenza A, Coronaviruses, Others SHELTON, CT / ACCESSWIRE / May 20, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the strong antiv...

NNVC - NNVC Stock Earnings: Nanoviricides Beats EPS for Q3 2024

2024-05-15 12:53:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nanoviricides (NYSEMKT: NNVC ) just reported results for the third quarter of 2024. Nanoviricides reported earnings per share of -16 cents. This was above the analyst esti...

NNVC - NanoViricides GAAP EPS of -$0.16

2024-05-15 07:18:20 ET More on NanoViricides Seeking Alpha’s Quant Rating on NanoViricides Historical earnings data for NanoViricides Financial information for NanoViricides Read the full article on Seeking Alpha For further details see: Na...

NNVC - NanoViricides Has Filed its Quarterly Report

NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection SHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly Report on F...

NNVC - A Novel Broad-Spectrum Antiviral with Activity Against RSV

Complete Survival of Animals Lethally Infected into Lungs with RSV Achieved Upon NV-387 Oral Treatment SHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity o...

NNVC - NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City

SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, will be attending the EF Hutton Annual Globa...

NNVC - A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox

NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, say...

NNVC - NanoViricides, TC BioPharm, Holdco Nuvo among healthcare movers

2024-05-07 10:01:47 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

NNVC - XBP and MNTX among mid-day movers

2024-05-06 13:17:53 ET More on Mid-day movers & stocks. Manitex International, Inc. 2024 Q1 - Results - Earnings Call Presentation Manitex International, Inc. (MNTX) Q1 2024 Earnings Call Transcript Manitex International, Inc. (MNTX) Q4 2023 Earnings Call Transcr...

NNVC - NanoViricides, Outset Medical, EyePoint Pharmaceuticals among healthcare movers

2024-05-06 10:01:41 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

Previous 10 Next 10